Work

Pre-Clinical In Vitro Evaluation of BCL-2 Antisense Compound GenasenseTM (G3139; Genta, Inc.) as a Targeted Pro-Apoptotic Agent for Leukemias with t(4;11)(q21;q23) Translocations.

Year: 2005

Type: article

Source: Blood

Authors: Blaine W. Robinson, Kathyrn C. Behling, Jeffrey S. Barrett, Manish Gupta, Jessicca M. Rege, Jonni S. Moore, Andrew D. Bantly, Junhyong Kim, George Hii, Cheryl L. Willman, Jeffrey Potter, Peter C. Adamson, Carolyn A. Felix

Institutions: Children's Hospital of Philadelphia, University of Pennsylvania, University of New Mexico

Language: English

Topic: Cell death mechanisms and regulation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2567884238

FWCI: 0.231

Cites:

Cited by: 2

Related to: 10